Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual Use Cessation MOST Screening Trial
NCT06474299Phase 4Recruiting
- Sponsor
- University of Wisconsin–Madison
- Start
- Sep 2024
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline, nicotine patch in Tobacco Use Disorder (TUD), e-cigarette or vaping-associated lung injury (EVALI), sponsored by University of Wisconsin–Madison. Started Sep 2024; status: recruiting.
02
Drugs
vareniclinenicotine patch
03
Conditions
Tobacco Use Disorder (TUD)e-cigarette or vaping-associated lung injury (EVALI)
Beyond the preview
Go deeper on NCT06474299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06474299.